BRIEF-Midazolam Nasal Spray met main goal of a late-stage trial in patients with seizure clusters
* Midazolam nasal spray (usl261) phase 3 trial meets primary efficacy endpoint in patients with seizure clusters Source text for Eikon:
Dec 19 Curasan AG :
* Resolves cash capital increase by up to 10 percent without subscription rights Source text for Eikon: Further company coverage: (Gdynia Newsroom)
April 26 Key healthcare stakeholders, led by the World Economic Forum, plan pilot programs this year to show the value of a new model for healthcare that would track and pay for treatment based on how well it works rather than the volume of care.